Compounding Drugs for Intrathecal Use
Choosing the correct intrathecal drug medication or combination of medications has historically been an art of trial and error with some historical perspective. More recently, compounding pharmacies have had increased national scrutiny in safety practices. In this chapter, we will review options for intrathecal drug delivery management, as well as explore guides for compounding sterile preparations, and provide the reader with stability data on common compounded formulations of intrathecal drugs.
KeywordsCompounding Intrathecal Stability Sterile preparation Safety
- 6.Convention USP. 2009; Chapter 797, United States Pharmacopeia/National Formulary 1st ed. US Pharmacopeia; 4139.Google Scholar
- 7.Kastango E. The ASHP discussion guide for compounding sterile preparations: summary and implementation of USP Chapter 797 2004. ASHP Publishing.Google Scholar
- 8.Outterson K. Regulating compounding pharmacies after NECC. N Engl J Med. 2012;367:1986–72.Google Scholar
- 13.Trissel L, editor. Trissel’s stability of compounded formulations. 4nd ed. Washington, DC: APHA Publications; 2009.Google Scholar
- 14.O’Neil M, Smith A, Heckelman P, et al., editors. Merck index. 13th ed. New York: Wiley; 2001.Google Scholar